We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$14.8B
AUM Growth
+$198M
Cap. Flow
+$49.3M
Cap. Flow %
0.33%
Top 10 Hldgs %
21.47%
Holding
817
New
24
Increased
116
Reduced
615
Closed
23

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$75.5M
2
TT icon
Trane Technologies
TT
+$47M
3
MSFT icon
Microsoft
MSFT
+$46M
4
AAPL icon
Apple
AAPL
+$43.4M
5
ALLE icon
Allegion
ALLE
+$38M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$46.6M
2
MU icon
Micron Technology
MU
+$32.5M
3
BABA icon
Alibaba
BABA
+$30.2M
4
BA icon
Boeing
BA
+$26.2M
5
NFLX icon
Netflix
NFLX
+$23.8M

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Financials 16.7%
3 Healthcare 12.96%
4 Consumer Discretionary 10.39%
5 Communication Services 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTD icon
376
Mettler-Toledo International
MTD
$28.6B
$6.06M 0.04%
8,609
-443
-5% -$325K
WCN
377
Waste Connections
WCN
$42B
$6.02M 0.04%
65,513
-31,329
-32% -$2.9M
OMC icon
378
Omnicom Group
OMC
$23.4B
$5.97M 0.04%
76,219
-5,397
-7% -$429K
FNV icon
379
Franco-Nevada
FNV
$46B
$5.88M 0.04%
64,516
-3,152
-5% -$289K
LH icon
380
Labcorp
LH
$25.9B
$5.82M 0.04%
40,297
-2,934
-7% -$428K
REG icon
381
Regency Centers
REG
$14.1B
$5.81M 0.04%
83,647
-5,619
-6% -$374K
IP icon
382
International Paper
IP
$22B
$5.81M 0.04%
146,600
-11,402
-7% -$446K
HAL icon
383
Halliburton
HAL
$26.6B
$5.79M 0.04%
307,384
-54,599
-15% -$1.13M
MRVL icon
384
Marvell Technology
MRVL
$196B
$5.77M 0.04%
230,901
-348,555
-60% -$8.74M
PPLI
385
People Inc
PPLI
$3.1B
$5.7M 0.04%
146,426
-7,431
-5% -$317K
REGN icon
386
Regeneron Pharmaceuticals
REGN
$80.8B
$5.66M 0.04%
20,407
-9,704
-32% -$2.87M
MGA icon
387
Magna International
MGA
$18.8B
$5.65M 0.04%
105,876
-8,244
-7% -$411K
J icon
388
Jacobs Solutions
J
$17B
$5.63M 0.04%
74,442
+16,413
+28% +$1.17M
CFG icon
389
Citizens Financial Group
CFG
$30.6B
$5.61M 0.04%
158,713
-11,378
-7% -$397K
MNST icon
390
Monster Beverage
MNST
$88.4B
$5.6M 0.04%
192,868
-96,888
-33% -$2.94M
CPRT icon
391
Copart
CPRT
$27.5B
$5.59M 0.04%
278,316
-18,460
-6% -$358K
EVRG icon
392
Evergy
EVRG
$19.2B
$5.59M 0.04%
83,971
-8,542
-9% -$540K
RF icon
393
Regions Financial
RF
$26.8B
$5.58M 0.04%
353,043
-28,953
-8% -$438K
K
394
DELISTED
Kellanova
K
$5.58M 0.04%
92,261
-5,549
-6% -$317K
PFG icon
395
Principal Financial Group
PFG
$24.3B
$5.56M 0.04%
97,351
-4,735
-5% -$267K
BBY icon
396
Best Buy
BBY
$17.3B
$5.56M 0.04%
80,611
-4,699
-6% -$328K
MXIM
397
DELISTED
Maxim Integrated Products
MXIM
$5.54M 0.04%
95,701
-5,015
-5% -$291K
FANG icon
398
Diamondback Energy
FANG
$52.7B
$5.53M 0.04%
61,447
+2,592
+4% +$258K
NUE icon
399
Nucor
NUE
$62.1B
$5.48M 0.04%
107,610
-5,367
-5% -$280K
MCHP icon
400
Microchip Technology
MCHP
$46B
$5.39M 0.04%
115,944
-55,770
-32% -$2.53M

Similar funds

Aviva's Q3 2019 Portfolio in Review

As of Q3 2019, Aviva held 817 positions worth $14.8B, up 1.4% from $14.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Aviva's Q3 2019 filing shows 24 new, 116 increased, 615 reduced and 23 closed positions. Its largest new stake was Lennox International: 50,194 shares worth $12.2M. The largest sale was Pfizer, an estimated $46.6M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Aviva's largest Q3 2019 buy was Lennox International: 50,194 shares worth $12.2M.
  • Aviva added most to Comcast in Q3 2019, an estimated $75.5M increase.
  • Aviva's biggest Q3 2019 reduction was Pfizer, cutting an estimated $46.6M.
  • Aviva fully exited Worldpay, Inc. in Q3 2019, selling an estimated $13.8M.
  • Aviva's ten largest holdings make up 21% of its $14.8B portfolio in Q3 2019.
  • Aviva opened 24 new positions and closed 23 in Q3 2019.
  • Aviva's portfolio value rose 1.4% quarter-over-quarter to $14.8B.

Based on Aviva's 13F filing for Q3 2019, filed 12 Nov 2019.